From R&D to Commercialization: Challenges for Cell Therapy Manufacturing

In order for cell therapy companies to successfully evolve from R&D to commercialization, there are many lessons learned from the protein business that can be applied to the cell therapy market.
Jeff Craig, Global Director, Marketing and Business Development, ATMI LifeSciences


Listen to the audio cast here

[sc_embed_player_template1 fileurl=”″]